# US 2020/0393355 A1 · Methods for detecting particles present in a cell composition

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0393355 A1
- Document ID: US20200393355A1
- Status: Published application
- Kind: A1
- Application number: 16/970,917
- Filed: 2019-02-28
- Published: 2020-12-17
- Earliest claimed: 2018-02-28
- Assignees: Juno Therapeutics, Inc.
- Applicants: Juno Therapeutics, Inc.
- Inventors: Brittney Jo LIVINGSTON; Hai YUE
- Web page: https://patentgrep.com/patent/US20200393355A1

## CPC

- G01N 15/1456: {without spatial resolution of the texture or inner structure of the particle, e.g. processing of pulse signals}
- G01N 15/1468: {with spatial resolution of the texture or inner structure of the particle}
- G01N 33/54313: {the carrier being characterised by its particulate form}
- G01N 2015/0053: {in liquids, e.g. trouble}
- G01N 2015/1461: {Coincidence detecting; Circuits therefor}
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Provided are methods of detecting, assessing or determining the presence or absence of particles, such as bead particles, present in a cell composition. Also provided are articles of manufacture and kits for use in the methods.

## Claims

### Claim 1

A method for detecting the presence or absence of non-cell particles in a cell composition, the method comprising the steps of:
a) incubating a sample comprising at least a portion of an input composition or a sample derived from the input composition, wherein said input composition comprises one or more cells and is likely to comprise or may comprise one or more non-cell particles in which said one or more non-cell particles is capable of emitting an autofluorescence, wherein the incubating is under conditions to induce lysis of cells to produce an output composition; and
b) analyzing the output composition or a portion thereof by fluorescence imaging of the autofluorescence of the one or more non-cell particles to determine the presence or absence of the one or more non-cell particles in the sample.

### Claim 2

A method for detecting the presence or absence of non-cell particles in a cell composition, the method comprising analyzing an output composition or a portion thereof by fluorescence imaging of an autofluorescence to determine the presence or absence of non-cell particles in the output composition, wherein the output composition is a sample of at least a portion of an input composition that has been incubated under conditions to induce lysis of cells, wherein the input composition comprises one or more of the cells and is likely to comprise or may comprise one or more non-cell particles in which said one or more non-cell particles is capable of emitting the autofluorescence.

### Claim 3 (depends on 1, 2)

The method of claim 1 or claim 2, wherein the one or more non-cell particles is a residual non-cell particle present in the input composition following a step to remove or reduce non-cell particles from a cell composition comprising the one or more cells and one or more non-cell particles.

### Claim 4 (depends on 1, 2, 3)

The method of any of claims 1-3, wherein prior to the analyzing the output composition is enriched for the one or more non-cell particles by a step involving selecting for the one or more non-cell particles present in the output composition.

### Claim 5

A method for detecting the presence or absence of non-cell particles in a cell composition, the method comprising:
(a) processing a cell composition comprising cells and non-cell particles under conditions to remove or reduce the non-cell particles of the cell composition, thereby producing an input composition comprising one or more of the cells and that may comprise one or more non-cell particles that is a residual non-cell particle, wherein the one or more non-cell particles is capable of emitting an autofluorescence;
(b) incubating a sample comprising at least a portion of the input composition or a sample derived from the input composition, wherein the incubating is under conditions to induce lysis of the one or more cells to produce an output composition;
(c) enriching for the one or more non-cell particles in the output composition by a step involving selecting for the one or more non-cell particles present in the output composition; and
(d) analyzing the enriched output composition or a portion thereof by fluorescence imaging of the autofluorescence to determine the presence or absence of non-cell particles in the sample.

### Claim 6 (depends on 4, 5)

The method of claim 4 or claim 5, wherein the one or more non-cell particles are magnetic or paramagnetic and the selection comprises exposing the non-cell particles to a magnet or magnetic field.

### Claim 7 (depends on 1, 2, 3, 4, 5, 6)

The method of any of claims 1-6, wherein the analyzing the output composition by fluorescence imaging comprises obtaining a fluorescent image, optionally a fluorescent micrograph, of the output composition or a portion thereof, and determining fluorescent intensity of image objects from the fluorescent image.

### Claim 8 (depends on 7)

The method of claim 7, wherein the method further comprises obtaining a brightfield image, optionally a brightfield micrograph, of the output composition or a portion thereof, wherein the one or more non-cell particles are distinguished from one or more other components in the output composition by assessing the size, area, and/or circularity of image objects from the fluorescent image and/or brightfield image.

### Claim 9

A method for detecting the presence or absence of non-cell particles in a cell composition, the method comprising
(i) illuminating an output composition or a portion thereof with one or more light sources to generate an illuminated sample, wherein at least one light source is capable of exciting an autofluorescence, wherein said output composition is a sample of at least a portion of an input composition that has been incubated under conditions to induce lysis of cells, wherein the input composition comprises one or more of the cells and is likely to comprise or may comprise the one or more non-cell particles in which said one or more non-cell particles is capable of emitting the autofluorescence;
(ii) capturing one or more images of the illuminated sample, wherein at least one image is a fluorescent image, and optionally at least one image is a brightfield image;
(iii) analyzing the presence or absence of image objects from the one or more images for one or more parameters selected from size, area, fluorescent intensity, brightfield intensity, and/or circularity, thereby determining the presence or absence of one or more non-cell particles.

### Claim 10 (depends on 9)

The method of claim 9, wherein prior to the illuminating the output composition is enriched for the one or more non-cell particles by a step involving selection for the one or more non-cell particles present in the output composition.

### Claim 11 (depends on 10)

The method of claim 10, wherein the one or more non-cell particles is magnetic or paramagnetic and the selection comprises magnetic selection.

### Claim 12 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11)

The method of any of claims 1-11, wherein the analyzing detects singlets, doublets or singlets and doublets of the non-cell particles.

### Claim 13 (depends on 7, 8, 9, 10, 11, 12)

The method of any of claims 7-12, wherein an image object is detected as a non-cell particle if the image object comprises a fluorescent signal, optionally above a background signal in a control sample and:
(i) the image object comprises a circularity of at or at least 0.4;
(ii) the image object comprises a diameter of between 1 μm and 20 μm, inclusive; and/or
(iii) the image object comprises an area of less than 130 μm2.

### Claim 14 (depends on 13)

The method of claim 13, wherein an image object is detected as a non-cell particle if:
(i) the image object comprises a circularity of at or at least 0.4, at or at least 0.5, at or at least 0.6, at or at least 0.7, at or at least 0.8, or at or at least 0.9;
(ii) the image object comprises a diameter of between 3 μm and 15 μm, inclusive; and/or
(iii) the image object comprises an area of between 0.5 μm2 and 50 μm2;

### Claim 15 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)

The method of any of claims 1-14, wherein:
(A) an image object is detected as a singlet non-cell particle if the image object comprises a fluorescent signal, optionally above a background signal in a control sample, and:
(i) the image object comprises a circularity of at or at least 0.7;
(ii) the image object comprises a diameter of between 1 μm and 7.5 μm, inclusive; and/or
(iii) the image object comprises an area of less than 65 μm2; and
(B) an image object is detected as a doublet non-cell particle if the image object comprises a fluorescent signal, optionally above a background signal in a control sample, and:
(i) the image object comprises a circularity of between or between about 0.4 and 0.6;
(ii) the image object comprises a diameter of between 2 μm and 15 μm, inclusive; and/or
(iii) the image object comprises an area of less than 130 μm2.

### Claim 16 (depends on 15)

The method of claim 15, wherein:
(A) an image object is detected as a singlet non-cell particle if the image object comprises a fluorescent signal, optionally above a background signal in a control sample, and:
(i) the image object comprises a circularity of between or between about 0.7 and 1.0;
(ii) the image object comprises a diameter of between or between about 1 and 5 μm; and/or
(iii) the image object comprises an area of less than 65 μm2; and
(B) an image object is detected as a doublet non-cell particle if the image object comprises a fluorescent signal, optionally above a background signal in a control sample, and:
(i) the image object comprises a circularity of between or between about 0.4 and 0.6;
(ii) the image object comprises a diameter of between or between about 2 and 10 μm; and/or
(iii) the image object comprises an area of less than 130 μm2.

### Claim 17 (depends on 13, 14, 15, 16)

The method of any of claims 13-16, wherein the control sample is a composition produced by incubating a cell composition comprising the one or more cells but not comprising the one or more non-cell particles, optionally wherein the incubating is under conditions to induce lysis of cells to produce an output composition.

### Claim 18 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17)

The method of any of claims 1-17, wherein the analyzing further comprises enumerating the number of non-cell particles determined to be present in the sample.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)

The method of any of claims 1-18, wherein:
the analyzing is carried out using a computer-implemented image analysis; or
one or more steps of the method is carried out by a machine, a robot and/or a computer-implemented algorithm.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19)

The method of any of claims 1-19, wherein one or more steps of the method is high-throughput and/or automated.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20)

The method of any of claims 1-20, wherein the input composition is derived from a cell composition, said cell composition comprising one or more cells and one or more of the non-cell particles in which said one or more non-cell particles comprises a biomolecule capable of binding to a macromolecule on the surface of the one or more cells.

### Claim 22 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21)

The method of any of claims 1-21, wherein the input composition is produced by a method comprising:
(1) mixing one or more cells with one or more of the non-cell particles; and
(2) removing one or more of the non-cell particles from the cells.

### Claim 23 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22)

The method of any of claims 1-22, wherein the one or more of the non-cell particles comprise one or more biomolecules capable of binding to a macromolecule on the surface of a cell.

### Claim 24 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)

The method of any of claims 1-23, wherein the incubating under conditions to induce lysis of cells comprises incubating the sample with a solution comprising a bleach, optionally wherein the bleach is a chlorine-based bleach.

### Claim 25 (depends on 24)

The method of claim 24, wherein the solution comprising bleach further comprises a detergent, optionally wherein the detergent is one or more of Triton X-100, Triton X-114, NP-40, Brij-35, Brij-58, Tween 20, Tween 80, digitonin, octyl glucoside, octyl thioglucoside, sodium dodecyl sulfate (SDS), 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) and CHAPSO.

### Claim 26 (depends on 24, 25)

The method of claim 24 or claim 25, wherein the incubating under conditions to induce lysis of cells comprises incubating the sample with bleach wherein the sample is incubated with bleach at a concentration of about 0.1%, 0.2%, 0.3%, 0.4%, 0.5%, 1%, 1.5%, 2%, 3%, 4%, 5%, 6%, 7% or 8% (v/v) bleach, or a range defined by any two of the foregoing values.

### Claim 27 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26)

The method of any of claims 1-26, wherein:
the incubating is carried out for at least or at least about 30 seconds, 1 minute, 2 minutes, 3 minutes, 4 minutes, 5 minutes, 10 minutes, 20 minutes or 30 minutes; or
the incubating is carried out from or from about 30 seconds to 30 minutes, 1 minute to 20 minutes, 1 minute to 10 minutes or 1 minute to 5 minutes.

### Claim 28 (depends on 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27)

The method of any of claims 4-27, wherein the enriching reduces or removes cells or cell debris from the output composition.

### Claim 29 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)

The method of any of claims 1-28, wherein prior to the analyzing the method further comprises rinsing or washing the output composition with a wash solution, optionally wherein the wash solution comprises a detergent.

### Claim 30 (depends on 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method of any of claims 9-29, wherein prior to the capturing the method further comprises rinsing or washing the output composition with a wash solution, optionally wherein the wash solution comprises a detergent.

### Claim 31 (depends on 29, 30)

The method of claim 29 or claim 30, wherein rinsing or washing the output composition comprises pelleting the one or more non-cell particles and removing a volume or reducing a volume of the output composition.

### Claim 32 (depends on 29, 30, 31)

The method of any of claims 29-31, wherein the detergent is one or more of Triton X-100, Triton X-114, NP-40, Brij-35, Brij-58, Tween 20, Tween 80, digitonin, octyl glucoside, octyl thioglucoside, sodium dodecyl sulfate (SDS), 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) and CHAPSO.

### Claim 33 (depends on 25, 32)

The method of claim 25 or claim 32, wherein the detergent is or comprises Tween 20.

### Claim 34 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33)

The method of any of claims 1-33, wherein the concentration of cells in the sample of at least a portion of the input composition is at least or at least about 2×105 cells/mL, at least or at least about 5×105 cells/mL, at least or at least about 1×106 cells/mL, at least or at least about 5×106 cells/mL, at least or at least about 1×107 cells/mL, at least or at least about 5×107 cells/mL, at least or at least about 1×108 cells/mL or at least or at least about 5×107 cells/mL.

### Claim 35 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34)

The method of any of claims 1-34, wherein the volume of the output composition or a portion thereof is at or about or is at least at or about 50 μL, 60 μL, 70 μL, 75 μL, 100 μL, 125 μL, 200 μL, 250 μL, 500 μL, 750 μL, 1 mL, 2 mL, 3 mL, 4 mL, 5 mL, 6 mL, 7 mL, 8 mL, 9 mL, or 10 mL, or a range defined by any two of the foregoing values.

### Claim 36 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35)

The method of any of claims 1-35, wherein the volume of the output composition is at least at or about or is at or about 70 μL.

### Claim 37 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36)

The method of any of claims 1-36, wherein prior to the analyzing the method comprises mixing the output composition under conditions to agitate the one or more cell particles in the sample.

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method of any of claims 1-37, wherein during the one or more steps of the method the output composition is processed under conditions to reduce sample retention on a surface during the processing.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The method of any of claims 1-38, wherein the one or more non-cell particles is or comprises beads.

### Claim 40 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39)

The method of any of claims 1-39, wherein one or more of the non-cell particles, optionally one or more beads, has a diameter of 1.0 μm to 10.0 μm or 1.0 μm to 5.0 μm.

### Claim 41 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40)

The method of any of claims 1-40, wherein the one or more of the non-cell particles, optionally one or more beads, has a diameter that is substantially the same as the average diameter of a cell in the cell composition or is within 5-fold, 4-fold, 3-fold, 2-fold or 1.5-fold greater or less than the average diameter of a cell in the cell composition.

### Claim 42 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41)

The method of any of claims 1-41, wherein the one or more non-cell particles, optionally one or more beads, has a diameter, or an average diameter, of greater than or greater than about 3.5 μm but no more than about 9 μm or no more than about 8 μm or no more than about 7 μm or no more than about 6 μm or no more than about 5 μm.

### Claim 43 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42)

The method of any of claims 1-42, wherein the one or more non-cell particles, optionally one or more beads, comprises a diameter, or an average diameter, of or about 4.5 μm.

### Claim 44 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43)

The method of any of claims 1-43, wherein one or more of the non-cell particles, optionally one or more beads, comprise a magnetic core, a paramagnetic core or a superparamagnetic core.

### Claim 45 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44)

The method of any of claims 1-44, wherein the one or more non-cell particles, optionally one or more beads, is inert.

### Claim 46 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45)

The method of any of claims 1-45, wherein the one or more non-cell particles, optionally one or more beads, is or comprises a polystyrene surface, and optionally comprises a magnetic or superparamagnetic core.

### Claim 47 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46)

The method of any of claims 21-46, wherein the one or more biomolecules is present on, or attached to, the surface of the one or more non-cell particles, optionally the one or more beads.

### Claim 48 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47)

The method of any of claims 21-47, wherein the one or more biomolecule is an affinity reagent capable of selecting, isolating or enriching one or more cells in a sample.

### Claim 49 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48)

The method of any of claims 21-48, wherein the one or more biomolecules is a stimulatory agent or agents capable of stimulating one or more cells in the sample.

### Claim 50 (depends on 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49)

The method of any of claims 21-49, wherein the one or more biomolecule is an antibody or an antigen-binding fragment thereof.

### Claim 51 (depends on 49, 50)

The method of claim 49 or claim 50, wherein the stimulatory agent or agents is capable of activating one or more intracellular signaling domains of one or more components of a TCR complex and/or one or more intracellular signaling domains of one or more costimulatory molecules.

### Claim 52 (depends on 49, 50, 51)

The method of any of claims 49-51, wherein the stimulatory agent or agents comprises a primary agent that specifically binds to a member of a TCR complex and a secondary agent that specifically binds to a T cell costimulatory molecule.

### Claim 53 (depends on 52)

The method of claim 52, wherein the primary agent specifically binds to CD3 and/or the costimulatory molecule is selected from the group consisting of CD28, CD137 (4-1-BB), OX40, and ICOS.

### Claim 54 (depends on 52, 53)

The method of claim 52 or claim 53, wherein the primary agent is or comprises an anti-CD3 antibody or antigen-binding fragment thereof and the secondary agent is or comprises an anti-CD28 antibody or antigen-binding fragment thereof.

### Claim 55 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54)

The method of any of claims 1-54, wherein the one or more cells is an animal cell or the cell composition comprises animal cells.

### Claim 56 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55)

The method of any of claims 1-55, wherein the one or more cells is a human cell or the cell composition comprises human cells.

### Claim 57 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56)

The method of any of claims 1-56, wherein the one or more cells is a stem cell or the cell composition comprises stem cells.

### Claim 58 (depends on 57)

The method of claim 57, wherein the stem cell is an induced pluripotent stem cell (iPSC).

### Claim 59 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58)

The method of any of claims 1-58, wherein the one or more cell is an immune cell or the cell composition comprises immune cells.

### Claim 60 (depends on 59)

The method of claim 59, wherein the immune cell is a T cell, B cell, macrophage, neutrophil, natural killer (NK) cell or dendritic cell.

### Claim 61 (depends on 60)

The method of claim 60, wherein the cell is a T cell and the one or more non-cell particles comprises or is attached to a stimulating agent or agents, wherein said stimulating agent or agents is an anti-CD3 antibody or antigen-binding fragment thereof and/or anti-CD28 antibody or an antigen-binding fragment thereof.

### Claim 62 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60)

The method of any of claims 1-60, wherein the one or more non-cell particles comprise one or more affinity reagents to effect selection, isolation or enrichment of a cell from a cell composition prior to the incubating.

### Claim 63 (depends on 48, 62)

The method of claim 48 or claim 62, wherein the affinity reagent comprises an antibody or antigen-binding fragment thereof that specifically binds to a cell surface protein on the one or more cells.

### Claim 64 (depends on 63)

The method of claim 63, wherein the cell surface protein is selected from among CD2, CD3, CD4, CD5, CD8, CD25, CD27, CD28, CD29, CD31, CD44, CD45RA, CD45RO, CD54 (ICAM-1), CD127, MHCI, MHCII, CTLA-4, ICOS, PD-1, OX40, CD27L (CD70), 4-1BB (CD137), 4-1BBL, CD30L, LIGHT, IL-2R, IL-12R, IL-1R, IL-15R; IFN-gammaR, TNF-alphaR, IL-4R, IL-10R, CD18/CD11a (LFA-1), CD62L (L-selectin), CD29/CD49d (VLA-4), a Notch ligand, Delta-like 1/4, Jagged 1/2, CCR1, CCR2, CCR3, CCR4, CCR5, CCR7, and CXCR3.

### Claim 65 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64)

The method of any of claims 1-64, wherein the incubating is performed at a temperature that is about 15° C. to 30° C., 18° C. to 28° C. or 20° C. to 25° C.

### Claim 66 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65)

The method of any of claims 1-65, wherein the incubating is performed at a temperature that is about 23° C.

### Claim 67

An article of manufacture, comprising:
a container comprising a solution comprising bleach and/or detergent for effecting cell lysis;
packaging material; and
a label or package insert comprising instructions for detecting the presence or absence of non-cell particles in a cell composition; wherein the instructions specify carrying out the steps of any of methods 1-66.
